154 related articles for article (PubMed ID: 1357005)
1. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.
Schofield JB; Mansi J; Camplejohn RS; Lane DP; Fisher C
J Clin Pathol; 1992 Aug; 45(8):664-7. PubMed ID: 1357005
[TBL] [Abstract][Full Text] [Related]
2. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M
Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
Jain S; Filipe MI; Hall PA; Waseem N; Lane DP; Levison DA
J Clin Pathol; 1991 Aug; 44(8):655-9. PubMed ID: 1679766
[TBL] [Abstract][Full Text] [Related]
6. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
7. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.
Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
Histopathology; 1991 Jul; 19(1):21-7. PubMed ID: 1680784
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
9. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
10. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen in endometrial adenocarcinomas of endometrioid type correlated with histologic grade, stage, previous hormonal treatment, and survival.
Nielsen AL; Nyholm HC
Hum Pathol; 1993 Sep; 24(9):1003-7. PubMed ID: 7504648
[TBL] [Abstract][Full Text] [Related]
12. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
Teague K; el-Naggar A
Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
[TBL] [Abstract][Full Text] [Related]
14. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer.
Visscher DW; Wykes S; Kubus J; Crissman JD
Breast Cancer Res Treat; 1992; 22(2):111-8. PubMed ID: 1356517
[TBL] [Abstract][Full Text] [Related]
16. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells.
Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M
Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489
[TBL] [Abstract][Full Text] [Related]
20. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
